MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Effect of PD medication on disease progression as measured by rate of change in MDS_UPDRS and DaT SBR in PPMI study

    J. Cedarbaum, K. Evans, M. Yang, J. Xiao (Cambridge, MA, USA)

    Objective: In clinical trials for new PD therapies, it is common for patients to start to take approved symptomatic PD medications during the study. The…
  • 2018 International Congress

    Efficacy of zonisamide on motor symptoms in dementia with Lewy bodies: A post-hoc analysis of a phase 3 study

    H. Maruyama, M. Murata, T. Odawara, K. Hasegawa, R. Kajiwara, H. Takeuchi, K. Kosaka (Tokyo, Japan)

    Objective: To characterize the efficacy of zonisamide in improving motor symptoms, we performed a post-hoc analysis using data from a phase 3 study that evaluated…
  • 2018 International Congress

    Proof-of-Principle Quantitative EEG Study of CX-8998, an Oral, Potent and Selective T-Type Calcium antagonist in development for symptomatic treatment of Essential Tremor and Parkinson’s disease Tremor

    S. Papapetropoulos, M. Lee, S. Boyer (Cambridge, MA, USA)

    Objective: To study the pharmacodynamics (PD) of CX-8998, using pharmaco-electroencephalography (phEEG) and define plasma concentrations of CX-8998 which are pharmacologically active on objective CNS parameters.…
  • 2018 International Congress

    Motor and non-motor correlates of APOE-ε4 mediated cerebrospinal fluid concentrations of biomarkers of amyloidogenesis and neurodegeneration in dementia with Lewy bodies compared with Alzheimer’s dementia and healthy controls

    F. Oliveira, M. Miraldo, E. Castro-Neto, F. Machado, S. Almeida, S. Matas, P. Bertolucci, M. Naffah-Mazzacoratti (São Paulo, Brazil)

    Objective: To study associations of cerebrospinal fluid biomarkers of amyloidogenesis and neurodegeneration with motor and non-motor aspects of daily experiences in dementia with Lewy bodies…
  • 2018 International Congress

    Molecular immunological action and epigenetic modification of the human papillomavirus vaccination and associated neuropsychiatric side effects

    N. Kanzato, K. Nakachi, Y. Takahashi (Okinawa, Japan)

    Objective: To investigate the clinical manifestations of neuropsychiatric side effects after the Human papillomavirus (HPV) vaccine, and to investigate the immunological actions and epigenetic modification.…
  • 2018 International Congress

    Using tablet devices to educate patients about dystonia and botulinum toxin for movement disorders

    S. Bobker, A. Hanineva, P. Popa, H. Ellsworth, X. Wu, I. Diaz, N. Hellmers, C. Henchcliffe, H. Sarva (New York, NY, USA)

    Objective: To assess the efficacy of tablet-based learning modules for patient education in an outpatient movement disorders center. Background: Educational materials improve patient understanding, and…
  • 2018 International Congress

    Evaluating the Knowledge, Practice and Experience about Management of Parkinson’s Disease among Physiotherapists in Ghana: A Cross sectional Survey

    M. Agoriwo (Accra, Ghana)

    Objective: To identify the level of Parkinson's disease (PD)-specific knowledge about the clinical manifestations, evidence-based practice, skills and experience in the management of PD among…
  • 2018 International Congress

    Autosomal dominant PANK2 mutation resulting in cervical dystonia with iron accumulation in the basal ganglia

    M. van_der_Weijden, R. Lambrechts, E. Nibbeling, J. Groen, T. de Koning, O.. Sibon, M. Tijssen, D. Verbeek (Groningen, Netherlands)

    Objective: Identification and functional analysis of the disease-causing gene in a family with dominantly inherited cervical dystonia. Background: With the introduction of next generation sequencing…
  • 2018 International Congress

    Comparison of clinical characteristics and treatment outcomes of botulinum neurotoxin in routine clinical practice between hemifacial spasm with and without the Babinski-2 sign in Thai patients: An exploratory study

    A. Suengtaworn, Y. Pitakpatapee, P. Soontrapa, C. Hurst, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To compare the clinical characteristics, along with the treatment outcomes of botulinum neurotoxin (BoNT) between HFS patients with and without the BBK-2 sign as…
  • 2018 International Congress

    Identifying therapeutic targets from spontaneous beneficial brain lesions

    J. Joutsa, L. Shih, A. Horn, M. Reich, J. Hsu, O. Wu, N. Rost, M. Fox (Charlestown, MA, USA)

    Objective: To determine whether rare cases in which spontaneously occurring brain lesions improved tremor can be used to identify a therapeutic target. Background: The search…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley